Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Indian J Ophthalmol ; 68(10): 2291-2293, 2020 Oct.
Article in English | MEDLINE | ID: covidwho-796779

ABSTRACT

Coronavirus disease 2019 (COVID-19) is a form of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has been declared a pandemic by the World Health Organization (WHO). Ocular manifestations related to COVID-19 are uncommon with conjunctivitis being reported in a few cases. We report a unique case of vasculitic retinal vein occlusion (RVO) secondary to COVID-19 in a 52-year-old patient who presented with the diminution of vision in the left eye 10 days after he tested positive for SARS-CoV-2. All investigations for vasculitis were negative. This case supports the mechanism of thrombo-inflammatory state secondary to the "cytokine-storm" as the pathogenesis for systemic manifestations of COVID-19.


Subject(s)
Betacoronavirus/pathogenicity , Coronavirus Infections/virology , Eye Infections, Viral/virology , Pneumonia, Viral/virology , Retinal Vasculitis/virology , Retinal Vein Occlusion/virology , Administration, Oral , Angiogenesis Inhibitors/therapeutic use , COVID-19 , Coronavirus Infections/diagnosis , Coronavirus Infections/drug therapy , Drug Therapy, Combination , Eye Infections, Viral/diagnosis , Eye Infections, Viral/drug therapy , Fluorescein Angiography , Glucocorticoids/therapeutic use , Humans , Intravitreal Injections , Male , Methylprednisolone/therapeutic use , Middle Aged , Pandemics , Pneumonia, Viral/diagnosis , Pneumonia, Viral/drug therapy , Ranibizumab/therapeutic use , Retinal Vasculitis/diagnosis , Retinal Vasculitis/drug therapy , Retinal Vein Occlusion/diagnosis , Retinal Vein Occlusion/drug therapy , SARS-CoV-2 , Tomography, Optical Coherence , Vascular Endothelial Growth Factor A/antagonists & inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL